MedTrace Logo

Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo

NCT04774809 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2022-07-13

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy and safety of SHR0302 ointment in adult patients with Vitiligo.

Conditions

  • Vitiligo

Interventions

DRUG

Low Dose SHR0302 Ointment BID

Low Dose SHR0302 Ointment BID

DRUG

High Dose SHR0302 Ointment BID

High Dose SHR0302 Ointment BID

OTHER

Placebo Comparator: Vehicle

Placebo

Sponsors & Collaborators

  • Reistone Biopharma Company Limited

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-29
Primary Completion
2022-03-21
Completion
2022-03-21

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04774809 on ClinicalTrials.gov